Finance

Lists
THYROCARE:NSE
Thyrocare Technologies Ltd
₹497,30
-0,74%
(-3,70) 1D
9 Okt., 15:30:03 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for THYROCARE...
Open
₹503,00
High
₹503,50
Low
₹490,90
Mkt. cap
79,15 mjd
Avg. vol.
272,22 k
Volume
346,02 k
Dividend
1,88%
Quarterly dividend
₹2,33
Ex-dividend date
23 Jun. 2026
P/E ratio
45,19
52-wk high
₹662,00
52-wk low
₹342,55
EPS
₹11,00
Shares outstanding
52,76 m
No. of employees
2 k
Open
₹503,00
High
₹503,50
Low
₹490,90
Mkt. cap
79,15 mjd
Avg. vol.
272,22 k
Volume
346,02 k
Dividend
1,88%
Quarterly dividend
₹2,33
Ex-dividend date
23 Jun. 2026
P/E ratio
45,19
52-wk high
₹662,00
52-wk low
₹342,55
EPS
₹11,00
Shares outstanding
52,76 m
No. of employees
2 k
News stories
From web sources and news partners
Profile
Thyrocare Technologies Limited is an Indian multinational chain of diagnostic and preventive care laboratories, headquartered in Navi Mumbai. As of 2021, the company has a total of 1,122 outlets and collection centers across India and parts of Nepal, Bangladesh and the Middle East. On 26 June 2021, Indian e-pharmacy and online healthcare aggregator PharmEasy's parent API Holdings acquired a 66.1% controlling stake in Thyrocare, making Thyrocare the first Indian listed company to be acquired by a startup. Wikipedia
About Thyrocare Technologies Ltd
CEO-
Employees1,91 k
Founded1996
HeadquartersNavi Mumbai, Maharashtra, Indië
SectorHealth care provider
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
2,17 mjd
1,96 mjd
2,24 mjd
2,40 mjd
Cost of goods sold
932,90 m
829,60 m
1,17 mjd
1,02 mjd
Cost of revenue
932,90 m
829,60 m
1,17 mjd
1,02 mjd
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
292,50 m
-
Operating expense
634,00 m
763,70 m
460,70 m
734,70 m
Total operating expenses
1,57 mjd
1,59 mjd
1,63 mjd
1,75 mjd
Operating income
598,40 m
362,00 m
613,70 m
647,80 m
Other non operating income
30,50 m
50,70 m
-112,20 m
41,50 m
EBT including unusual items
625,80 m
353,90 m
644,30 m
682,90 m
EBT excluding unusual items
625,80 m
415,50 m
525,80 m
682,90 m
Income tax expense
147,70 m
73,40 m
157,30 m
169,60 m
Effective tax rate
23,60%
20,74%
24,41%
24,84%
Other operating expenses
518,90 m
547,40 m
-126,20 m
609,80 m
Net income
479,90 m
290,10 m
471,10 m
521,90 m
Net profit margin
22,16%
14,84%
21,04%
21,74%
Earnings per share
-
2,11
2,98
3,22
Interest and investment income
-
-
34,00 m
-
Interest expense
-5,90 m
-
-15,20 m
-13,50 m
Net interest expenses
-5,90 m
-
18,80 m
-13,50 m
Depreciation and amortization charges
115,10 m
216,30 m
140,30 m
124,90 m
EBITDA
713,00 m
477,75 m
711,78 m
745,88 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme